A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma.
Publication
, Journal Article
Kaplan, LD; Jung, S; Johnson, JL; Linker, CA; Byrd, JC; Stock, W; Hsi, ED; Cheson, BD
Published in: Journal of Clinical Oncology
May 20, 2010
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
TPS306 / TPS306
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kaplan, L. D., Jung, S., Johnson, J. L., Linker, C. A., Byrd, J. C., Stock, W., … Cheson, B. D. (2010). A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma. Journal of Clinical Oncology, 28(15_suppl), TPS306–TPS306. https://doi.org/10.1200/jco.2010.28.15_suppl.tps306
Kaplan, L. D., S. Jung, J. L. Johnson, C. A. Linker, J. C. Byrd, W. Stock, E. D. Hsi, and B. D. Cheson. “A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma.” Journal of Clinical Oncology 28, no. 15_suppl (May 20, 2010): TPS306–TPS306. https://doi.org/10.1200/jco.2010.28.15_suppl.tps306.
Kaplan LD, Jung S, Johnson JL, Linker CA, Byrd JC, Stock W, et al. A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma. Journal of Clinical Oncology. 2010 May 20;28(15_suppl):TPS306–TPS306.
Kaplan, L. D., et al. “A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma.” Journal of Clinical Oncology, vol. 28, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2010, pp. TPS306–TPS306. Crossref, doi:10.1200/jco.2010.28.15_suppl.tps306.
Kaplan LD, Jung S, Johnson JL, Linker CA, Byrd JC, Stock W, Hsi ED, Cheson BD. A randomized phase II trial of maintenance versus consolidation bortezomib therapy following aggressive chemo-immunotherapy and autologous stem cell transplant for previously untreated mantle cell lymphoma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2010 May 20;28(15_suppl):TPS306–TPS306.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2010
Volume
28
Issue
15_suppl
Start / End Page
TPS306 / TPS306
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences